This web presentation presents an overview of FDA's requirements for approval/marketing of a Biosimilar (Generic Biologic) product. The webinar covers the Biosimilar product testing requirements (clinical and nonclinical) and the Biosimilar approval pathway.
Biosimilar (Generic) Biologics In The USA: Approval Pathway - Webinar by GlobalCompliancePanel
11 March 2014, Fremont, United States
Introduction
Venue
Online Event
Online Event, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA, Fremont, 94539, United States
Useful links
Organised by
GlobalCompliancePanel
Contact information
Mr John Robinson
161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA, United States, Fremont, 94539, United States of America
800 447 9407
Contact us by email
161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA, United States, Fremont, 94539, United States of America
800 447 9407
Contact us by email
Related events
7th International Conference on Nanomaterials Science and Mechanical Engineering
8 July 2025 08:00 - 11 July 2025 18:00, Aveiro, Portugal
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
European Glycoscience Community Webinar Series
25 January 2024 15:00 - 19 December 2024 18:00
Search
Advertisement
Spotlight
Explore
Membership
